choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Sativex

Sativex Newsletter
  • Tiny medicinal cannabis group Ananda inspired by $7bn trailblazer 28 Jul 2025 06:28 GMT

    … former executive of GW Pharmaceuticals, the medicinal cannabis company sold … of setbacks, including for Sativex, its first product, which … is being studied as a treatment for endometriosis, funded by … Dosing for phase II trials in endometriosis and chemotherapy …

  • Turkey Legalizes Medical Cannabis Sales In Pharmacies 25 Jul 2025 17:51 GMT

    … expanding patient access to such treatment. The Turkish Parliament this week … Commission on Narcotic Drugs (CND), the United Nations’ drug policy-making body … of sublingual cannabinoid medications, such as Sativex, with a doctor’s prescription. The …

  • Turkish Parliament Votes to Legalize Low-THC Medical Cannabis Product Sales 22 Jul 2025 17:30 GMT

    … be strictly limited to prescribed medical treatments.   The legislation puts the … its analgesic and antidepressant effects.   “We’re referring to pharmaceutical-grade products … new law, only medical CBD products, such as Sativex, were available via …

  • Confusing for doctors, inequitable for patients: why Australia’s medicinal cannabis system needs urgent reform 15 Jul 2025 07:55 GMT

    treatment-resistant conditions. The TGA clearly indicated medicinal … required of registered pharmaceuticals. In other words … doctors, whose prescribing has traditionally been guided by strong trial … TGA-approved medicinal cannabis products, Sativex, used to …

  • Does Medical Cannabis Alleviate Chronic Pain? 09 Jul 2025 12:35 GMT

    … there by specialist doctors. Germany legalized … Pharmaceutics at Penn State Neuroscience Institute, Pennsylvania, told Medscape Medicalremedy for millennia. But the classification of cannabis as a narcotic drug … different types of treatment.” What Should …

  • Medical Cannabis 08 Jul 2025 00:46 GMT

    … case-by-case basis. Doctors can either apply for … treatment of Dravet syndrome), medical cannabis isn’t subsidised under the Pharmaceutical … to be an antiinflammatory, antidepressant and anti-epilepsy, and … is involved in clinical trials using cannabis products …

  • The Myths of Medical Marijuana 26 Jun 2025 18:36 GMT

    … a commitment to promote trials of marijuana preparatory to … other treatments, to identify who might be harmed by the drug ( … the state’s 22,111 medical doctors. One survey of 520 … the development of pharmaceutical derivatives such as “Sativex”, which will be …

  • Protagenic Therapeutics Skyrockets on Merger with Phytanix Bio: A Biotech Powerhouse in the Making? 19 May 2025 22:40 GMT

    … who worked on Sativex and Epidiolex, two FDA-approved cannabinoid drugs. That kind … story, and with milestones like trial data or regulatory updates possible … mental health treatments, two of the hottest markets in biotech. As of …

  • Up in Smoke: Why New Zealand’s medical cannabis industry is struggling to make ends meet 06 May 2025 00:30 GMT

    … NZX. Aether Pacific Pharmaceuticals, formerly known as Medical Kiwi, entered liquidation … last week, public hospital doctors took the highly unusual step … part of a holistic treatment plan.” Glass did not … Newport says in hindsight, Sativex wasn’t a panacea but …

  • Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance 07 May 2025 17:52 GMT

    … We also advanced multiple trials across our zanidatamab development … treatment for narcolepsy1 and the only U.S. Food and Drug Administration (FDA … 217,737 198,716 Sativex 5,407 2, … those anticipated. JAZZ PHARMACEUTICALS PLC CONDENSED CONSOLIDATED STATEMENTS OF …

Satisfied with the content?

Continue to create your account.